Financhill is a comprehensive financial analysis platform that provides stock analysis, market data, investment tools, and educational resources to help investors make informed decisions.

How do I get started with Financhill?

You can start by creating a free account, exploring our stock analysis tools, setting up a watchlist, or trying our 7-day trial for full access to all premium features.

What features does Financhill offer?

Financhill offers stock analysis, technical charts, fundamental data, earnings information, dividend tracking, portfolio management, market screening tools, and educational resources.

What information is available on company profile pages?

Company profile pages provide comprehensive information including financial statements, earnings data, analyst ratings, institutional ownership, insider trading, SEC filings, and detailed business analysis.

How do I analyze a company's financial health?

Use our financial metrics including P/E ratio, debt-to-equity, revenue growth, profit margins, and cash flow analysis to evaluate a company's financial strength and growth potential.

How do I analyze CORT stock?

Use our comprehensive analysis tools including technical charts, fundamental metrics, earnings data, and Stock Score to evaluate CORT investment potential.

What is CORT stock price today?

The current CORT stock price is $38.34 as of 13 Feb '26. Get real-time CORT stock price, historical data, and price charts on Financhill.

Is CORT a good investment?

Evaluate CORT investment potential using our Stock Score, fundamental analysis, technical indicators, and earnings data. Consider your risk tolerance and investment goals.

What does Corcept Therapeutics, Inc. (CORT) do?

Corcept Therapeutics, Inc. (CORT) is a publicly traded company. View detailed company information, business model, financial statements, and corporate data on our CORT company profile page.

How to buy CORT stock?

To buy CORT stock, open a brokerage account, research the company using our analysis tools, and place your order through your broker. Always do your own research before investing.

What is the market cap of CORT?

View detailed market capitalization data and company valuation metrics for CORT on our comprehensive analysis page.

What is the P/E ratio of CORT?

Use our fundamental analysis tools to view CORT P/E ratio and compare valuation metrics with industry peers.

What are CORT earnings?

View CORT earnings data, quarterly results, revenue growth, and profit margins on our comprehensive earnings analysis page. Track earnings trends and analyst estimates.

Sell

37

CORT Quote, Financials, Valuation and Earnings

Last price:

$40.23

Seasonality move :

8.39%

Day range:

$38.00 - $40.85

52-week range:

$32.99 - $117.33

Dividend yield:

0%

P/E ratio:

43.81x

P/S ratio:

6.18x

P/B ratio:

6.38x

Volume:

1.4M

Avg. volume:

2.8M

1-year change:

-45.35%

Market cap:

$4B

Revenue:

$675M

EPS (TTM):

$0.88

Corcept Therapeutics, Inc. SEC Filings

Company	Filed	Form Type	Description
CORT Corcept Therapeutics, Inc.	05/01/2024	10-Q	10-Q filing on 05/01/2024	View Form
CORT Corcept Therapeutics, Inc.	11/01/2023	10-Q	10-Q filing on 11/01/2023	View Form
CORT Corcept Therapeutics, Inc.	08/02/2023	10-Q	10-Q filing on 08/02/2023	View Form
CORT Corcept Therapeutics, Inc.	05/03/2023	10-Q	10-Q filing on 05/03/2023	View Form
CORT Corcept Therapeutics, Inc.	11/03/2022	10-Q	10-Q filing on 11/03/2022	View Form
CORT Corcept Therapeutics, Inc.	08/04/2022	10-Q	10-Q filing on 08/04/2022	View Form
CORT Corcept Therapeutics, Inc.	05/05/2022	10-Q	10-Q filing on 05/05/2022	View Form
CORT Corcept Therapeutics, Inc.	11/03/2021	10-Q	10-Q filing on 11/03/2021	View Form
CORT Corcept Therapeutics, Inc.	07/29/2021	10-Q	10-Q filing on 07/29/2021	View Form
CORT Corcept Therapeutics, Inc.	05/06/2021	10-Q	10-Q filing on 05/06/2021	View Form
CORT Corcept Therapeutics, Inc.	11/03/2020	10-Q	10-Q filing on 11/03/2020	View Form
CORT Corcept Therapeutics, Inc.	08/04/2020	10-Q	10-Q filing on 08/04/2020	View Form
CORT Corcept Therapeutics, Inc.	05/04/2020	10-Q	10-Q filing on 05/04/2020	View Form
CORT Corcept Therapeutics, Inc.	02/24/2020	10-K	10-K filing on 02/24/2020	View Form
CORT Corcept Therapeutics, Inc.	11/07/2019	10-Q	10-Q filing on 11/07/2019	View Form
CORT Corcept Therapeutics, Inc.	08/01/2019	10-Q	10-Q filing on 08/01/2019	View Form
CORT Corcept Therapeutics, Inc.	05/09/2019	10-Q	10-Q filing on 05/09/2019	View Form
CORT Corcept Therapeutics, Inc.	02/26/2019	10-K	10-K filing on 02/26/2019	View Form
CORT Corcept Therapeutics, Inc.	11/02/2018	10-Q	10-Q filing on 11/02/2018	View Form
CORT Corcept Therapeutics, Inc.	08/09/2018	10-Q	10-Q filing on 08/09/2018	View Form
CORT Corcept Therapeutics, Inc.	05/09/2018	10-Q	10-Q filing on 05/09/2018	View Form
CORT Corcept Therapeutics, Inc.	02/28/2018	10-K	10-K filing on 02/28/2018	View Form
CORT Corcept Therapeutics, Inc.	11/03/2017	10-Q	10-Q filing on 11/03/2017	View Form
CORT Corcept Therapeutics, Inc.	08/02/2017	10-Q	10-Q filing on 08/02/2017	View Form
CORT Corcept Therapeutics, Inc.	05/02/2017	10-Q	10-Q filing on 05/02/2017	View Form
CORT Corcept Therapeutics, Inc.	03/06/2017	10-K	10-K filing on 03/06/2017	View Form
CORT Corcept Therapeutics, Inc.	11/02/2016	10-Q	10-Q filing on 11/02/2016	View Form
CORT Corcept Therapeutics, Inc.	08/03/2016	10-Q	10-Q filing on 08/03/2016	View Form
CORT Corcept Therapeutics, Inc.	05/04/2016	10-Q	10-Q filing on 05/04/2016	View Form
CORT Corcept Therapeutics, Inc.	03/10/2016	10-K	10-K filing on 03/10/2016	View Form

Related Companies

Get CORT Stock Alert

Signup to receive the latest stock alerts

Financial Ratios

CORT

Sector

P/E ratio

43.81x

23.16x

PEG ratio

6.39x

-0.01x

P/B ratio

6.38x

1.73x

Price / LTM sales

6.18x

1.50x

Growth Metrics

CORT

Sector

Revenue growth

13.75%

3.24%

Earnings growth

-60.52%

11.06%

Revenue (5-year growth)

17.11%

6.28%

Earnings forecast

$0.30

-$0.19

Profitability

CORT

Sector

Profitability FY 2024

$664.2M

$2.7M

Return on invested capital

15.84%

-33.62%

Return on assets

12.77%

-29.68%

Return on equity

16%

-39.33%

Earnings Date

Last Earnings Date

Nov

4

Next Earnings Date

Feb

25

Estimated Next Earnings Date

Feb

3

Balance Sheet

CORT

Sector

Total cash

$421.7M

$25.1M

Short term investments

$255.7M

$23.9M

Total assets

$840.6M

$72.8M

Long term debt

$5.3M

$2.5M

Stock Ideas

Buy

54

Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 64x

Buy or Sell?

Sell

46

Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 35x

Buy or Sell?

Sell

42

Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 29x

Buy or Sell?

Alerts

Sell

17

ICLR alert for Feb 13

ICON plc [ICLR] is up 18.47% over the past day.

Buy or Sell?

Buy

67

CGNX alert for Feb 13

Cognex Corp. [CGNX] is up 0.2% over the past day.

Buy or Sell?

Buy

77

IPGP alert for Feb 13

IPG Photonics Corp. [IPGP] is up 2.14% over the past day.

Buy or Sell?

Master Safe Stock Market Strategies

Get Paid To Own Stocks. Insure Your Stocks During Downtrends. Master "The Vacation Trade".

Corcept Therapeutics, Inc. SEC Filings

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Related Companies

Get CORT Stock Alert

Financial Ratios

Growth Metrics

Profitability

Earnings Date

Balance Sheet

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?

Is Lumentum The Best Laser Stock to Buy?

Is Planet Fitness Stock Undervalued?

Stock Ideas

Is NVDA Stock a Buy?

Is AAPL Stock a Buy?

Is GOOG Stock a Buy?

Alerts

ICLR alert for Feb 13

CGNX alert for Feb 13

IPGP alert for Feb 13

THE #1 STOCK ANALYSIS TOOLTO MAKE SMARTER BUY AND SELL DECISIONS

Watchlist

Stock Score

Seasonality

Analyze

Covered Calls

Valuation

Smart Money

Education

E-Book

Newsletters

Companies

Dividends

Traders Library

Big Movers

Stock Ideas

Stocks by Sector

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS